System C acquired medication management specialist WellSky in order to strengthen its electronic patient record (EPD) offering.
WellSky International, formerly known as JAC, is best known for its Electronic Medication Prescribing and Administration (EPMA) solutions. These solutions are used by around 200 NHS trusts and health boards in England, Scotland, Wales and Northern Ireland, in addition to a number of international clients.
The company, which employs 70 people in the UK, offers the UK’s broadest range of pharmaceuticals and EPMAs in the UK NHS market, including specialty prescription areas such as chemotherapy and pediatrics.
System C described the acquisition as highly strategic and said it will integrate Wellsky into its Careflow Cloud EPR suite, including clinical collaboration, care planning, electronic observations and patient flow.
“System C will invest significantly in product innovation, maintain interoperability with all hospital software systems and third party vendors,” the company said in a statement.
Dr Ian Denley, Co-CEO of System C, added: “WellSky International is the market leader in medication management solutions and has a long history of working with clinicians across the NHS. Its highly evolved clinical products are held in the highest regard by users, and we are delighted that they have joined the System C group.
Markus Bolton, co-CEO of System C, told Digital Health News that while the company “has a good prescribing module,” it does not have “the scope covered by Wellsky” because “the EPMA is very complex “.
He also confirmed that work has already started to integrate Wellsky into the System C EPR.
“It’s really good to have a prescription fully integrated into an EPD because you can get a lot of benefits,” he explained.
Cerner and Epic have integrated EPMA capabilities and System C is hoping the acquisition will help them compete with their NHS rivals.
WellSky’s extensive EPMA product portfolio includes critical care, emergency care, theaters, controlled medication and mobile solutions for the delivery of closed loop solutions to the bedside.
Bolton said the addition of a closed-loop EPMA solution will allow System C to help its customers achieve HIMSS 6 and 7 accreditation, a benchmark promoted by the Global Digital Exemplar program.
Robert Tysall-Blay, CEO of WellSky International, added, “System C is a perfect fit for us culturally and has the ambition, scale and product line we need to provide a management platform. world-class drugs as part of an integrated RPE.
Terms of the deal were not disclosed.